hTSC-derived Exosomes (ABX-004)

About Accelerated Biosciences

Accelerated Biosciences, founded in 2014, is a private, pre-revenue biotech platform company based in San Diego, CA, with a corporate presence in Philadelphia, PA. Its core innovation is a patented, ethically sourced human trophoblast stem cell (hTSC) platform, which serves as a versatile and scalable starting material for regenerative medicine. The company operates a partnership-driven business model, licensing its hTSCs, derived induced pluripotent stem cells (iPSCs), exosomes, and genetically engineered platforms (GEMS, CHO-GEMS) to biopharma partners and research institutions to accelerate their therapeutic development. Its strategy focuses on de-risking early-stage development for partners by providing clear IP, GMP-eligible cell lines, and standardized processes.

Therapeutic Areas

Other Regenerative Medicine (Broad) Drugs